Anaemia in haemodialysis patients of five European countries: Association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS)

412Citations
Citations of this article
182Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background. The Dialysis Outcomes and Practice Patterns Study (DOPPS) is a prospective, observational study based on data collected from nationally representative samples of haemodialysis facilities. The burden of anaemia in haemodialysis patients is substantial, leading to considerable morbidity, mortality and reduced quality of life. This study examines anaemia management and outcomes based on data from five European countries participating in the DOPPS: France, Germany, Italy, Spain and the UK. Methods. Baseline data on demographics, co-morbidities and anaemia management in 4591 haemodialysis patients from 101 nephrology facilities were collected in 1998-2000. Using multivariate Cox survival analyses to adjust for patient characteristics, relationships between haemoglobin concentration at study entry and rates of mortality and hospitalization were evaluated. Results. For a year 2000 sample of prevalent patients on haemodialysis > 180 days, mean haemoglobin concentration was 11.0 g/dl; 53% had a haemoglobin concentration ≥ 11 g/dl [1998-1999 = 44% (P < 0.05)]. In 2000, 84% of prevalent patients were prescribed recombinant human erythropoietin (rHuEpo). Higher haemoglobin concentrations were associated with decreased relative risk (RR) for mortality (RR = 0.95 for every 1 g/dl higher haemoglobin, P = 0.03) and hospitalization (RR = 0.96, P = 0.02). Patients with haemoglobin < 10 g/dl were 29% more likely to be hospitalized than patients with haemoglobin 11-12 g/dl (P < 0.001). Conclusion. Even after adjustment, lower haemoglobin concentrations were associated with higher morbidity and mortality in European haemodialysis patients. A trend to increased haemoglobin concentrations was observed following publication of the European Best Practice Guidelines (EBPG) on anaemia management for chronic kidney disease patients, but efforts must continue to achieve EBPG goals.

References Powered by Scopus

The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin

1993Citations
N/AReaders
Get full text

Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin

765Citations
N/AReaders
Get full text

The impact of anemia on cardiomyopathy, morbidity, and mortality in end- stage renal disease

720Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Anemia of chronic disease

2767Citations
N/AReaders
Get full text

Chronic Kidney Disease

2723Citations
N/AReaders
Get full text

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease

1847Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Locatelli, F., Pisoni, R. L., Combe, C., Bommer, J., Andreucci, V. E., Piera, L., … Held, P. J. (2004). Anaemia in haemodialysis patients of five European countries: Association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrology Dialysis Transplantation, 19(1), 121–132. https://doi.org/10.1093/ndt/gfg458

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 55

59%

Researcher 26

28%

Professor / Associate Prof. 8

9%

Lecturer / Post doc 4

4%

Readers' Discipline

Tooltip

Medicine and Dentistry 79

77%

Agricultural and Biological Sciences 9

9%

Nursing and Health Professions 8

8%

Pharmacology, Toxicology and Pharmaceut... 7

7%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free